NOV 03, 2021 9:00 AM PDT

Keynote Presentation: Expanding Access to Compassionate, Evidence-based Treatment for Opioid Use Disorders

Presented at: Opioid Crisis 2021
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

The United States continues to struggle with a comprehensive, effective strategy to address alcohol and drug-related morbidity and mortality. Challenges resulting from the COVID-19 pandemic worsened the situation. In 2020, over 93,000 Americans died from a drug-related poisoning (i.e., overdose) the majority of which included an opioid, a 24.9% increase over the prior year. Methamphetamine-related overdose deaths have nearly tripled over the past 4 years. This occurred at a time when significant federal, state, and local resources are invested in reducing opioid and other drug-related morbidity and mortality. This represents one of the greatest public health failures in our generation. Unlike our current pandemic, there is a longstanding body of robust science and practice-based evidence to mitigate the so-called “opioid crisis”. However, these programs are not fully accessible and barriers to their implementation continue. Using a set of statewide initiatives in Texas, this presentation discusses the underlying rationale, approach, and current status of a suite of systematic interventions intended to increase access to compassionate, evidence-based treatment for opioid and other substance use disorders including medication, stigma reduction, peer recovery support services, and systems level interventions.

Learning objectives:

1. Define critical components of a comprehensive approach to statewide OUD treatment program.

2. Identify ongoing challenges with care delivery for OUD treatment.

3. Explain how technology and telehealth helps to overcome barriers to access to evidence-based treatment for OUD in underserved areas.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
DEC 07, 2021 10:00 AM PST
C.E. CREDITS
DEC 07, 2021 10:00 AM PST
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
Loading Comments...
Show Resources